People: Poxel SA (POXEL.PA)
Mr. Richard Kender has served as a member of the board of directors of Poxel SA since 2015. He is Member of the Audit Committee and the Remuneration Committee, as well as Chairman of Business Development Committee and Member of the Strategic and Pricing Committee. Mr. Kender joined Merck & Co., Inc. in 1978, and served as Merck’s Vice President of Corporate Development from 1996 to 2000. In 2000, he was promoted to Senior Vice President and his responsibilities were expanded to include Corporate Licensing and Worldwide Business Development, where he managed Merck’s Mergers and Acquisitions, Licensing, Financial Evaluation and Analysis and Global Competitive Intelligence departments. Mr. Kender retired from Merck in September 2013. Mr. Kender currently serves on the board of directors and audit committee of Seres Therapeutics and on the board of directors of Abide Therapeutics. He holds a BS in Accounting from Villanova University and an MBA from Fairleigh Dickinson University.
|Total Annual Compensation, EUR||--|
|Restricted Stock Award, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||106,047|
|Fiscal Year Total, EUR||106,047|